Search
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.
-
The Diagnosis: Pharmaceutical Advertising is Still Advertising
DTC ads tend to break through more than the average ad, but brands should be wary of getting lost in a sea of sameness.
-
Healthcare Cybersecurity Insights + Tips
Discover research examining the attitudes, concerns, and impacts on medical device security, as well as cybersecurity across large and midsize healthcare delivery organizations.
-
The Future is Unwritten
Consumer behaviours from the pandemic are going remain in flux for years to come. Our advice: be patient.
-
Pharma utilization and cost management for self-funded employers
Listen in to hear healthcare research insights to drive pricing and market access strategies for the pharma sector.
-
Social Intelligence in Pharmaceuticals
In our latest white paper series, we explore the topic of digital readiness while breaking down the online commentary related to FDA’s approval of ADUHELM (aducanumab).
-
The Other Side of the Story
Read insights exploring COVID-19 treatment developments, including treatment landscape and how they are being used in real-world clinical practice.
-
Insights to Identify & Build Successful Partnerships Between DTx/Biopharma
Revisit our recorded webinar to hear a practical overview of the DTx industry and best practices for DTx and biopharma companies to create the future of patient-centric health together.
-
Why Digital Readiness is Critical for Pharma Marketers
Learn how to most effectively harness both physician and patient-derived insights from online channels and how you can add an entirely new layer of meaning to your research.